Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial Commences Enrollment with First European Implant of the Tack Endovascular System™

June 2, 2016 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has commenced enrollment, with the first patient treated by Prof. Klaus Brechtel at the Franziskus-Hospital in Berlin, Germany. The TOBA III study …

Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial Commences Enrollment with First European Implant of the Tack Endovascular System™ Read More »